GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
Bacteriostatic vials allow multiple entries, but each entry must be done with a new sterile syringe/needle to avoid introducing pathogens
Peptide Vials (BPC-157, 10 mg each): 8 weeks 3 vials (25.2 mg used) 12 weeks 5 vials (42 mg used) 16 weeks 6 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
Some people also use BPC 157 Peptides for: Ulcers in the stomach Intestinal damage (such as fistulas) Inflammatory disorders Bone and Joint healing growth rates Organ Damage Treatment for Celiacs and Crohns disease Research and Future Directions While research on BPC 157 Peptides continues to evolve, early studies have highlighted its potential in multiple mechanisms of action
Your hypothalamus and pituitary gland help regulate the release of growth hormone
Peptides generally safe based on widespread use reports
